Abstract

Microbially produced carboxylic acids (CAs) are considered key players in the implementation of more sustainable industrial processes due to their potential to replace a set of oil-derived commodity chemicals. Most CAs are intermediates of microbial central carbon metabolism, and therefore, a biochemical production pathway is described and can be transferred to a host of choice to enable/improve production at an industrial scale. However, for some CAs, the implementation of this approach is difficult, either because they do not occur naturally (as is the case for levulinic acid) or because the described production pathway cannot be easily ported (as it is the case for adipic, muconic or glucaric acids). Synthetic biology has been reshaping the range of molecules that can be produced by microbial cells by setting new-to-nature pathways that leverage on enzyme arrangements not observed in vivo, often in association with the use of substrates that are not enzymes’ natural ones. In this review, we provide an overview of how the establishment of synthetic pathways, assisted by computational tools for metabolic retrobiosynthesis, has been applied to the field of CA production. The translation of these efforts in bridging the gap between the synthesis of CAs and of their more interesting derivatives, often themselves non-naturally occurring molecules, is also reviewed using as case studies the production of methacrylic, methylmethacrylic and poly-lactic acids.

Highlights

  • Carboxylic Acids and Their Derivatives as “Green Building Blocks”E. coli overcame two bottlenecks: (i) the production of myo-inositol, which is not produced in this species due to the lack of a myo-inositol synthase; and (ii) the simplification of glucuronic acid to glucaric acid conversion, which in mammalian cells, takes five steps and in the synthetic pathway is mediated in a single step

  • Microbial production at an industrial scale of various carboxylic acids (CAs) considered of higher interest is already quite advanced, with the production of succinic, lactic or even itaconic acid representing good examples of processes that appear to be on track for a successful industrial implementation

  • It is expected that the results reported at an academic scale and the described new-to-nature biosynthetic pathways for various non-natural CAs and derivatives can pave the way for subsequent improvements in yields that could turn production at higher scales feasible and sustainable

Read more

Summary

Carboxylic Acids and Their Derivatives as “Green Building Blocks”

E. coli overcame two bottlenecks: (i) the production of myo-inositol, which is not produced in this species due to the lack of a myo-inositol synthase; and (ii) the simplification of glucuronic acid to glucaric acid conversion, which in mammalian cells, takes five steps and in the synthetic pathway is mediated in a single step. Improvements to this synthetic pathway were achieved using protein scaffolds (to modulate the effective concentration of myo-inositol at the synthetic complex) [15], fine-tuned regulation of the expression of the myo-inositol synthase [16] or by using different myo-inositol oxygenases [17].

Muconic Acid
Adipic Acid
Acrylic Acid
Levulinic Acid
Poly-Lactate Polymers
Methacrylic and Methyl-Methacrylic Acids
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call